Cargando…
Trichostatin A reverses the chemoresistance of lung cancer with high IGFBP2 expression through enhancing autophagy
Insulin-like growth factor (IGF) signaling plays an important role in tumorigenesis and metastasis. Here, we analyzed insulin-like growth factor (IGF) binding protein-2 (IGFBP2) expression in 81 lung cancer patients and 36 controls consisting of healthy and benign pulmonary lesion participants for c...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834489/ https://www.ncbi.nlm.nih.gov/pubmed/29500455 http://dx.doi.org/10.1038/s41598-018-22257-1 |
_version_ | 1783303653683101696 |
---|---|
author | Tang, Dongfang Yao, Ruyong Zhao, Dandan Zhou, Lin Wu, Yun Yang, Yang Sun, Yifeng Lu, Liming Gao, Wen |
author_facet | Tang, Dongfang Yao, Ruyong Zhao, Dandan Zhou, Lin Wu, Yun Yang, Yang Sun, Yifeng Lu, Liming Gao, Wen |
author_sort | Tang, Dongfang |
collection | PubMed |
description | Insulin-like growth factor (IGF) signaling plays an important role in tumorigenesis and metastasis. Here, we analyzed insulin-like growth factor (IGF) binding protein-2 (IGFBP2) expression in 81 lung cancer patients and 36 controls consisting of healthy and benign pulmonary lesion participants for comparison, then validated the IGFBP2 expression in additional 84 lung cancer patients, and evaluated the prognostic and chemoresistant significance of IGFBP2 in two cohorts respectively. Next we detected the reversal effect of trichostatin A (TSA) on chemoresistance in cell lines with high IGFBP2 expression. As a result, the mean expression of IGFBP2 in lung cancer patients was significantly higher than that in controls and increased with lung cancer progressed to advanced stage. In addition, high IGFBP2 expression was independently predictive for chemoresistance; over-expressed IGFBP2 enhances cell activity and TSA can reverse the chemoresistance induced by high IGFBP2 expression through enhancing autophagy. Furthermore, multivariate analysis showed that lung cancer patients whose blood IGFBP2 was higher had a poor survival outcome, with a hazard ratio of 8.22 (95%CI 1.78–37.92, P = 0.007) after adjustment for stage, histopathology, EGFR mutation, age, smoking and surgery. |
format | Online Article Text |
id | pubmed-5834489 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-58344892018-03-05 Trichostatin A reverses the chemoresistance of lung cancer with high IGFBP2 expression through enhancing autophagy Tang, Dongfang Yao, Ruyong Zhao, Dandan Zhou, Lin Wu, Yun Yang, Yang Sun, Yifeng Lu, Liming Gao, Wen Sci Rep Article Insulin-like growth factor (IGF) signaling plays an important role in tumorigenesis and metastasis. Here, we analyzed insulin-like growth factor (IGF) binding protein-2 (IGFBP2) expression in 81 lung cancer patients and 36 controls consisting of healthy and benign pulmonary lesion participants for comparison, then validated the IGFBP2 expression in additional 84 lung cancer patients, and evaluated the prognostic and chemoresistant significance of IGFBP2 in two cohorts respectively. Next we detected the reversal effect of trichostatin A (TSA) on chemoresistance in cell lines with high IGFBP2 expression. As a result, the mean expression of IGFBP2 in lung cancer patients was significantly higher than that in controls and increased with lung cancer progressed to advanced stage. In addition, high IGFBP2 expression was independently predictive for chemoresistance; over-expressed IGFBP2 enhances cell activity and TSA can reverse the chemoresistance induced by high IGFBP2 expression through enhancing autophagy. Furthermore, multivariate analysis showed that lung cancer patients whose blood IGFBP2 was higher had a poor survival outcome, with a hazard ratio of 8.22 (95%CI 1.78–37.92, P = 0.007) after adjustment for stage, histopathology, EGFR mutation, age, smoking and surgery. Nature Publishing Group UK 2018-03-02 /pmc/articles/PMC5834489/ /pubmed/29500455 http://dx.doi.org/10.1038/s41598-018-22257-1 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Tang, Dongfang Yao, Ruyong Zhao, Dandan Zhou, Lin Wu, Yun Yang, Yang Sun, Yifeng Lu, Liming Gao, Wen Trichostatin A reverses the chemoresistance of lung cancer with high IGFBP2 expression through enhancing autophagy |
title | Trichostatin A reverses the chemoresistance of lung cancer with high IGFBP2 expression through enhancing autophagy |
title_full | Trichostatin A reverses the chemoresistance of lung cancer with high IGFBP2 expression through enhancing autophagy |
title_fullStr | Trichostatin A reverses the chemoresistance of lung cancer with high IGFBP2 expression through enhancing autophagy |
title_full_unstemmed | Trichostatin A reverses the chemoresistance of lung cancer with high IGFBP2 expression through enhancing autophagy |
title_short | Trichostatin A reverses the chemoresistance of lung cancer with high IGFBP2 expression through enhancing autophagy |
title_sort | trichostatin a reverses the chemoresistance of lung cancer with high igfbp2 expression through enhancing autophagy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834489/ https://www.ncbi.nlm.nih.gov/pubmed/29500455 http://dx.doi.org/10.1038/s41598-018-22257-1 |
work_keys_str_mv | AT tangdongfang trichostatinareversesthechemoresistanceoflungcancerwithhighigfbp2expressionthroughenhancingautophagy AT yaoruyong trichostatinareversesthechemoresistanceoflungcancerwithhighigfbp2expressionthroughenhancingautophagy AT zhaodandan trichostatinareversesthechemoresistanceoflungcancerwithhighigfbp2expressionthroughenhancingautophagy AT zhoulin trichostatinareversesthechemoresistanceoflungcancerwithhighigfbp2expressionthroughenhancingautophagy AT wuyun trichostatinareversesthechemoresistanceoflungcancerwithhighigfbp2expressionthroughenhancingautophagy AT yangyang trichostatinareversesthechemoresistanceoflungcancerwithhighigfbp2expressionthroughenhancingautophagy AT sunyifeng trichostatinareversesthechemoresistanceoflungcancerwithhighigfbp2expressionthroughenhancingautophagy AT luliming trichostatinareversesthechemoresistanceoflungcancerwithhighigfbp2expressionthroughenhancingautophagy AT gaowen trichostatinareversesthechemoresistanceoflungcancerwithhighigfbp2expressionthroughenhancingautophagy |